Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-12-006850
Filing Date
2012-12-31
Accepted
2012-12-31 13:53:40
Documents
1
Period of Report
2012-12-26

Document Format Files

Seq Description Document Type Size
1 LANSDOWNE PARTNERS AUSTRIA GMBH - ALEXZA PHARMACEUTICALS, INC. p1346169.html 3  
1 LANSDOWNE PARTNERS AUSTRIA GMBH - ALEXZA PHARMACEUTICALS, INC. p1346169.xml 3 5624
  Complete submission text file 0000919574-12-006850.txt   7188
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Issuer) CIK: 0001344413 (see all company filings)

EIN.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address WALLNERSTRASSE 3/21 WIEN C4 1010
Business Address WALLNERSTRASSE 3/21 WIEN C4 1010 (43) 1 22 789-0
LANSDOWNE PARTNERS AUSTRIA GMBH (Reporting) CIK: 0001536071 (see all company filings)

State of Incorp.: C4 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-51820 | Film No.: 121293199